References
- MeyerDvan SchalkwykJTextbook of Ophthalmology: A Review of Current Medical Therapy for Primary Open Angle GlaucomaNew Delhi, IndiaJaypee Brothers20023
- TomidaIPertweeRGAzuara-BlancoACannabinoids and glaucomaBr J Ophthalmol20048870871315090428
- ThakurGANikasSPMakriyannisACB1 cannabinoid receptor ligandsMini Rev Med Chem2005563164016026309
- MorseHNUeber eine neue Darstellungsmethode der Acetylamidophenole. [About a new method of synthesis of Acetylamidophenole]Ber Deutscher Chem Ges187811232233 German
- HogestattEDJonssonBAErmundAConversion of acetaminophen to the bioactive N-acylphenol-amine AM404 via fatty acid amide hydro-lase-dependent arachidonic acid conjugation in the nervous systemJ Biol Chem2005280314053141215987694
- OttaniALeoneSSandriniMFerrariABertoliniAThe analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptorsEur J Pharmacol200653128028116438952
- BertoliniAFerrariAOttaniAGuerzoniSTacchiRLeoneSParacetamol: new vistas of an old drugCNS Drug Rev20061225027517227290
- PacherPBatkaiSKunosGThe endocannabinoid system as an emerging target of pharmacotherapyPharmacol Rev20065838946216968947
- RomanoMRLogranoMDCannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channelsBr J Pharmacol200614791792516474412
- Pinar-SueiroSRodríguez-PuertasRVecinoECannabinoid applications in glaucomaArch Soc Esp Oftalmol201186162321414525
- OstapowiczGFontanaRJSchiodtFVResults of a prospective study of acute liver failure at 17 tertiary care centers in the United StatesAnn Intern Med200213794795412484709
- HeardKGreenJLBaileyJEA randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcoholAliment Pharmacol Ther20072628329017593074
- Van der BijlPVan EykADMeyerDEffects of three penetration enhancers on transcorneal permeation of cyclosporineCornea20012050550811413407
- Van der BijlPEngelbrechtAHVan EykADMeyerDComparative permeability of human and rabbit corneas to cyclosporine and tritiated waterJ Ocul Pharmacol Ther20021841942712419093
- Van der BijlPVan EykADSeifartHIMeyerDDiffusion of metronidazole released from aqueous solution and a gel through human and rabbit corneasJ Ocul Pharmacol Ther20042042142915650517
- Van EykADVan der BijlPMeyerDIn vitro diffusion of the immu-nosuppressant tacrolimus through human and rabbit corneasJ Ocul Pharmacol Ther20072314615117444803
- OstapowiczGFontanaRJSchiodtFVResults of a prospective study of acute liver failure at 17 tertiary care centers in the United StatesAnn Intern Med200213794795412484709
- QuigleyHANumber of people with glaucoma worldwideBr J Ophthalmol1996803893938695555
- StraikerAMaguireCMakieKLocalization of cannabinoid CB1 receptors in the human anterior eye and retinaInvest Ophthalmol Visual Sci1999402442244810476817
- PorcellaACasellasPGessaGLCannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuanaMol Brain Res1998582402459685662
- GreenKPedersonJEEffect of D9-tetrahydrocannabinol on aqueous dynamics and ciliary body permeability in the rabbitExp Eye Res1973154995074702382
- SugrueMFNew approaches to antiglaucoma therapyJ Med Chem199740279328099288160
- GreenKPodosSMAntagonism of arachidonic acid-induced ocular effects by D9-tetrahydrocannabinolInvest Ophthalmol Vis Sci197413422429
- GreenKKreaseECMcIntyreOLInteraction between D9-tetrahydro-cannabinol and indomethacinOphthalmic Res20013321722011464074
- GrayGABattistiniBWebbDJEndothelins are potent vasoconstrictors, and much more besidesTrends Pharmacol Sci200021384010733432
- HaeffigerIOMeyerPFlammerJThe vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology?Surv Ophthalmol1994391231327801220
- NicolelaMTFerrierSNMorrisonCAEffects of cold-induced vasospasm in glaucoma. The role of endothelin-1Invest Ophthalmol Vis Sci2003442565257212766058
- MechoulamRPanikashiviliDShohamiECannabinoids and brain injury: therapeutic implicationsTrends Mol Med20028586111815270
- European Glaucoma SocietyTerminology and Guidelines for Glaucoma2nd edSavona, ItalyDogma2003
- HeijlALeskeMCBengtssonBEarly Manifest Glaucoma Trial GroupReduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma TrialArch Ophthalmol20021201268127912365904
- LaineKJarvinenTSavinainenJLaitinenJTPateDWJarvinenKEffects of topical nandamide-transport inhibitors, AM404 and olvanil, on intraocular pressure in normotensive rabbitsPharm Res20011849449911451037
- MoynihanRFDA fails to reduce accessibility of paracetamol despite 450 deaths a yearBMJ200232567812351357
- WatkinsPBKaplowitzNSlatteryJTAminotransferase elevations in healthy adults receiving 4 grams of paracetamol daily: a randomized controlled trialJAMA2006296879316820551
- TempleARBensonGDZinsenheimJRSchweinleJEMulticenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6–12 months) safety of paracetamol in adult patients with osteoarthritisClin Ther20062822223516678643
- BradleyJDBrandtKDKatzBPKalasinskiLARyanSIComparison of an antiinfammatory dose of ibuprofen, an analgesic dose of ibuprofen, and paracetamol in the treatment of patients with osteoarthritis of the kneeN Engl J Med199132587912052056
- TomidaIAzuara-BlancoAHouseHFlintMPertweeRGRobsonPJEffect of sublingual application of cannabinoids on intraocular pressure: a pilot studyJ Glaucoma20061534935316988594
- CrandallJMatragoonSKhalifaYMNeuroprotective and intraocular pressure lowering effects of (−)Δ9-tetrahydrocannabinol in a rat model of glaucomaOphthalmic Res200739697517284931
- MartinBRCellular effects of cannabinoidPharmacol Rev19863845742872689